| Current Price | $4.67 | Mkt Cap | $289.4M |
|---|---|---|---|
| Open | $4.69 | P/E Ratio | 0.00 |
| Prev. Close | $4.67 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.64 - $4.75 | Volume | 180,771 |
| 52-Wk Range | $2.50 - $6.00 | Avg. Daily Vol. | 381,453 |
| Current Price | $4.67 | Mkt Cap | $289.4M |
|---|---|---|---|
| Open | $4.69 | P/E Ratio | 0.00 |
| Prev. Close | $4.67 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.64 - $4.75 | Volume | 180,771 |
| 52-Wk Range | $2.50 - $6.00 | Avg. Daily Vol. | 381,453 |
The best Bull and Bear pitches based on recency and number of recommendations.
Stock Pump and Dump. It is paying people to boost its stock, though it doesn't even have a product in stores yet, though later this year it is supposed to have some crappy vitamin on the shelves of GNC.
Read the most recent pitches from players about CDXC.
Recs
DrChimera
(65.95)
Submitted: 1/7/2018 2:11:11 AM :
Start Price:
$6.38
NASDAQ:CDXC Score:
-64.27
Great Product
Recs
futurist123
(< 20)
Submitted: 2/11/2017 7:21:20 PM :
Start Price:
$2.75
NASDAQ:CDXC Score:
+7.93
I personally bought this stock at $2.42...just getting this into CAPS now.
I like the product story behind Niagen. As of now, it seems to be a key focus and I like the story regarding how it could be a billion dollar ingredient via inclusion in other products.
The stock had two bad storylines over the course of the last year. It was hit with what amounted to a smear article on seekingalpha, which saw a precipitous drop. And recently, it announced it was suing its largest customer. I feel that customer does not have leverage over CDXC, and thus the lawsuit should be settled and return to normal operating procedure, as CDXC supplies the key ingredients for its only product as of now.
Add to all of this that the company is advised by a Nobel laureate, and we see an undervaluation.
Recs
bradster75
(22.26)
Submitted: 9/12/2014 7:47:28 AM :
Start Price:
$3.84
NASDAQ:CDXC Score:
-66.14
Has some good contracts inked which should increase revenues for their new ingredient products Niagen and Purenergy. If they become profitable, which is a good probability in the next few quarters given the contracts, then the stock will soar.
Find the members with the highest scoring picks in CDXC.
allstar31 (99.94) Score: +192.89
Stock Pump and Dump. It is paying people to boost its stock, though it doesn't even have a product in stores yet. Later this year it is supposed to have some crappy vitamin on the shelves of GNC. Don't believe the hype.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| allstar31 | 99.94 | 7/25/2011 |
|
5Y | $5.25 | -11.05% | +181.85% | +192.89 | 2 Comments | |
| snowgoon42 | 95.10 | 4/6/2015 |
|
NS | $5.04 | -7.34% | +81.99% | +89.33 | 0 Comment | |
| patatepoil6 | 93.33 | 1/7/2016 |
|
5Y | $4.26 | +9.62% | +92.34% | +82.72 | 0 Comment | |
| jed71 | 30.57 |
|
|
5Y | $4.08 | +14.46% | +76.43% | +61.97 | 0 Comment | |
| KnowNoFear | 25.42 | 7/20/2012 |
|
5Y | $2.19 | +113.24% | +174.67% | +61.43 | 0 Comment | |
| ccastineyra | 82.53 | 5/29/2012 |
|
5Y | $2.10 | +122.38% | +181.85% | +59.46 | 0 Comment | |
| roolbreakers | 31.22 | 8/15/2016 |
|
5Y | $4.06 | +15.02% | +71.64% | +56.61 | 0 Comment | |
| onthewallst | 28.18 | 12/16/2015 |
|
5Y | $3.63 | +28.65% | +82.06% | +53.41 | 0 Comment | |
| junkmarket | < 20 | 2/27/2012 |
|
5Y | $2.10 | +122.38% | +173.28% | +50.90 | 0 Comment | |
| MotleyViking | 96.80 | 6/8/2012 |
|
5Y | $2.01 | +132.34% | +182.82% | +50.48 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
